31 July 2018
Abzena signs protein engineering agreement with NYU Langone Health
Cambridge, UK, 30 July 2018 – Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has entered into a master service agreement with one of...
17 July 2018
Innovate UK Announces Precision Medicines Innovation Fund
Improving diagnosis and treatment of disease: new innovation fund … UK businesses can apply for simultaneous grant funding and venture capital investment in precision medicine projects. There is simultaneous grant and venture capital funding available for small and medium...
4 July 2018
Abzena and Telix sign strategic manufacturing and bioconjugation agreement
Cambridge, UK and Melbourne, Australia, 2 July 2018 – Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed GMP manufacturing and...
26 June 2018
SurgaColl Partners with Sparta to Deliver High-Quality Tissue Regeneration Products, Improve Accessibility and Time-to-Market
HAMILTON, N.J., June 25, 2018 /PRNewswire/ -- Sparta Systems, Inc., the leading provider of quality and regulatory affairs management software, announced it is partnering with SurgaColl™ Technologies, an innovative medical device company supplying novel orthobiologics...
5 June 2018
Acquisition of BWB by CAF Group wins East Midlands Deal of the Year
The acquisition of Catapult portfolio company BWB Consulting by CAF Group has won the Deal of the Year award at the recent East Midlands Dealmakers Dinner. The Award, which was sponsored by UBS and open to all transactions across the Midlands region, was described by the judges...
22 May 2018
Cytox launches collaboration agreement with Mayo Clinic to evaluate novel genetic based approaches for assessing Alzheimer’s risk
Important research collaboration for pioneering PRS approach … Oxford & Manchester, UK. Cytox, a precision medicine front-runner which today is commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s and other...
11 May 2018
New Early-Warning Device To Detect Infection In Dialysis Patients Completes Successful Clinical Pilot In Manchester
Manchester - 8th May 2018. An innovative solution designed to identify infection in dialysis patients has completed a successful pilot clinical investigation following a funding award from Health Innovation Manchester. Manchester-based medical device company Microbiosensor...
9 May 2018
Cytox in Collaboration with AKESOgen Extends Genetic Test for Assessing Alzheimer's Risk to Include Saliva Samples
Pioneering PRS approach verified for banked DNA, blood and saliva samples … OXFORD, England & MANCHESTER, England & ATLANTA--(BUSINESS WIRE)--Cytox, a precision medicine testing company commercializing polygenic risk scoring (PRS) and other approaches for assessing...
27 March 2018
Maxwellia announces funding to accelerate its mission for Self Care
Investment will expedite conversion of prescription medicines to over the counter … Alderley Park, UK, 26 March 2018 – Maxwellia, a pioneering ‘prescription to over the counter’ medicines company, today announced that it has raised £700,000 in early-stage...
27 March 2018
Yospace To Showcase The World’s Most Advanced Server-Side Ad Insertion Technology At NAB Show
Yospace will be demonstrating the capabilities of its server-side ad insertion platform at NAB 2018, a multi-award-winning solution that is widely regarded as the most advanced in the world. Yospace’s platform, which is fast becoming the de facto standard server-side...